Avadel Pharma (NASDAQ: AVDL) reported Q4 EPS of ($0.46), versus ($0.25) reported last year. Revenue for the quarter came in at $20.9 million, versus $34.75 million reported last year.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.